Biomarker Testing Services
KCAS Bio offers a number of analytical platforms to perform single or multiplexed biomarker analysis. We have experience on a variety of matrices (biological fluids & tissues) within a wide range of therapeutic areas.
Bringing the latest technical innovation to biomarker services
KCAS Bio offers considerations about which matrix to use and assay sensitivity. We help clients determine whether a qualified assay can be used to generate sufficient data on a biomarker’s potential usefulness, or if more thorough analytical validation will be required.
Biomarker assay services
The KCAS Bio team is well versed in the full scope of biomarker applications, including:
• In-depth knowledge and experience in method development and kit adaption
• Fit-for-Purpose method qualification/validation
• Single analyte and multiplex analysis
• Measurements in both animal and human matrices
• Nominal or no-cost qualification of most multiplex panels
Biomarker technologies include:
Soluble Biomarkers:
LBA, qPCR, ddPCR, LC-MS/MS, MSD
Cellular Biomarkers:
ELISpot, Flow Cytometry, qPCR, ddPCR, Single-Cell Proteomics
Fit-for-Purpose Biomarker Applications
Our 40 years of experience has prepared us to make your most nuanced project a success. Our approach with fit-for-purpose projects includes:
- Needs-based, fit-for-purpose qualification or validation
- Consultative in determining your needs
- Experience in both method development and kit adaption
- Single-plex and multiplex analysis
- Measurements in both animal and human matrices
- Nominal or no-cost qualification of most multiplex panels
KCAS Bio is biomarker ready
Biomarker assays are an important part of the KCAS Bio full-service assay capabilities. Our dedicated and highly experienced scientists use state-of-the-art technologies for biomarker analysis to support preclinical, clinical and exploratory projects where fast data turn-around may be of essence.
Our people
Related services
Resources & insights
Blogs
KCAS Bio offers a wide range of biomarker services, from cell-based to soluble biomarker analysis, including ligand binding assays (LBA), across a variety of matrix types. Soluble biomarker analysis can be achieved on multiple platforms depending on factors such as sample type, required sensitivity, and whether multiplexing is…
Blogs
Biomarker assay development is pivotal to clinical research and the success of a study, yet the journey from qualification to validation is often complex. In this blog, we discuss four must-know essentials to optimize your assay development process. 1. Understand the Context of Use: Qualification vs. Validation The FDA emphasizes…
Blogs
When it comes to developing new therapies for inflammatory bowel diseases (IBD), having robust and reliable bioanalytical support is crucial. From the early stages of drug discovery to Phase III clinical trials, our comprehensive bioanalytical solutions are designed to enhance and accelerate your drug development journey in a GCP…
Agile, responsive and easy to work with
We prepare and adapt our services based on a deep understanding of your drug development ambitions and wider business objectives.